newsletter issue 1 july 2016 - lsrnw.ac.uk · 7/1/2016 · vegf therapy for triple-negative breast...

8

Upload: others

Post on 28-Jul-2020

3 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

TRANSCRIPT

Page 1: Newsletter Issue 1 July 2016 - lsrnw.ac.uk · 7/1/2016 · VEGF therapy for triple-negative breast cancer therapy. Prof Doak, Design and evaluation of an antibody-drug conjugate

Page 2: Newsletter Issue 1 July 2016 - lsrnw.ac.uk · 7/1/2016 · VEGF therapy for triple-negative breast cancer therapy. Prof Doak, Design and evaluation of an antibody-drug conjugate

Page 3: Newsletter Issue 1 July 2016 - lsrnw.ac.uk · 7/1/2016 · VEGF therapy for triple-negative breast cancer therapy. Prof Doak, Design and evaluation of an antibody-drug conjugate

Page 4: Newsletter Issue 1 July 2016 - lsrnw.ac.uk · 7/1/2016 · VEGF therapy for triple-negative breast cancer therapy. Prof Doak, Design and evaluation of an antibody-drug conjugate

Page 5: Newsletter Issue 1 July 2016 - lsrnw.ac.uk · 7/1/2016 · VEGF therapy for triple-negative breast cancer therapy. Prof Doak, Design and evaluation of an antibody-drug conjugate

Page 6: Newsletter Issue 1 July 2016 - lsrnw.ac.uk · 7/1/2016 · VEGF therapy for triple-negative breast cancer therapy. Prof Doak, Design and evaluation of an antibody-drug conjugate

Page 7: Newsletter Issue 1 July 2016 - lsrnw.ac.uk · 7/1/2016 · VEGF therapy for triple-negative breast cancer therapy. Prof Doak, Design and evaluation of an antibody-drug conjugate

Page 8: Newsletter Issue 1 July 2016 - lsrnw.ac.uk · 7/1/2016 · VEGF therapy for triple-negative breast cancer therapy. Prof Doak, Design and evaluation of an antibody-drug conjugate

6.30.14-7.6.14 JACK FM & KIRVIN DOAK COMMUNICATIONS

Vegf @ ant vegf

Dual inhibition of Ang-2 and VEGF receptors normalizes tumor … · VEGF therapy showed abnormally high levels of Ang-2 (28), and the Ang-1/Ang-2 ratio correlated positively with

English with Mrs. Doak

VEGF Dan Preeklamsi

Research Effects of Anti-VEGF Treatment Duration on Tumor ... · Cancer Therapy: Preclinical Effects of Anti-VEGF Treatment Duration on Tumor Growth, Tumor Regrowth, and Treatment

VEGF Bioassay - Promega

Physicians Anti-VEGF therapy and Intraocular Pressure

Die lymphangiogenen Wachstumsfaktoren VEGF-C und VEGF-D: Teil 2: Die Rolle von VEGF-C und VEGF-D bei Krankheiten des Lymphsystems

VEGF-B promotes cancer metastasis through a VEGF- A ... · VEGF-B remain an enigma (18, 19). Initially, VEGF-B was shown to stimulate endothelial cell activity and angiogenesis (18)

Vascular endothelial growth factor (VEGF) and VEGF receptor … · Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomas

Doak Structural - Phase 2 Plans.pdf

Research Paper The VEGF rise in blood of bevacizumab ...€¦ · anti-VEGF therapy was addressed. A VEGF rise was observed in blood of bevacizumab patients but not in chemotherapy

Anti – VEGF Agents

Anti-VEGF therapy in pituitary carcinoma · Anti-VEGF therapy in pituitary carcinoma ... The tumor was biopsied and morphological analysis showed severe cell injury, vas-cular abnormalities

Bevacizumab therapy normalizes the pathological intraocular … · 2010. 10. 28. · Bevacizumab therapy normalizes the pathological intraocular environment beyond neutralizing VEGF

BÖBREK KANSERİNDE GÜNCEL TEDAVİYAKLAŞIMIkanser.org/saglik/upload/Urolojik_Tumor/Böbrek_Kanserinde_Guncel... · Part of this increase in ... VEGF-B VEGF-A VEGF-C VEGF-D Sorafenib

Current Perspectives on the Use of Anti-VEGF Drugs as ... · current perspectives on the use of anti-VEGF drugs as adjuvant therapy in the management of neovascular glaucoma (NVG)

Developing Inhibitors of VEGF-C/VEGF-D - opthea.com · Developing Inhibitors of VEGF-C/VEGF-D ... This presentation has been prepared by Circadian Technologies Ltd ACN 006 ... 10

Combined Ang-2 and VEGF Targeting Therapies in …file.scirp.org/pdf/JCT_2013093014525569.pdf · geted therapy with small molecule VEGF targeted agents (Sunitinib, Cediranib) in a

Anti-VEGF Therapy

Anti VEGF Therapy in Ophthalmology

Supplementary Appendix · Web viewVersion 2.01 Version 2.02 Version 2.03 Version 7.01 Markers VEGF-A VEGF-A, VEGF-C, PDGF-C, G-CSF VEGF-A, VEGF-C, PDGFC VEGF-A Capture antibody type

Anti-VEGF thErApy FOr Diabetic Macular eDeMa - Retina …retinatoday.com/pdfs/0314_supp2.pdf · Supplement to March 2014 Anti-VEGF thErApy FOr Diabetic Macular eDeMa A roundtable

ANGIOGENESI e VEGF

Anti-VEGF/VEGFR Therapy for Cancer: Reassessing the Target · anti–VEGF-A/VEGFR drugs (9); they also provided strong evidence that VEGF-A was necessary for the maintenance of the

Genetic Disorders By; Robin Doak

THE ROLE OF ANTI-VEGF THERAPY IN RETINA DISEASES ASSOCIATED WITH MACULAR EDEMA

Retinal vascular disease...Anti-VEGF therapy (anti-vascular growth factor inhibitors) and laser therapy. •2. A vitrectomy is performed to remove the vitreous gel and blood and to

Resistance to anti-VEGF therapy mediated by autocrine IL-6 ...cancerres.aacrjournals.org/content/canres/early/... · Resistance to anti-VEGF therapy mediated by autocrine IL-6/STAT3

;JJ>K ANNUAL EDUCATIONAL DR. DANIEL LEARNED JOINS …AMD with a new drug therapy called Opthea. Speci cally, the company s investigative mole-cule (OPT-302) blocks VEGF-C and VEGF-D

100 regras para ser feliz (beverley doak)

Photodynamic Therapy for Choroidal Neovascularization · The use of VPDT in CNV has decreased substantially with the availability of anti-VEGF therapy. Subsequent to FDA approval

Anti-VEGF and anti-VEGF receptor induced vascular alteration ...Anti-VEGF– and anti-VEGF receptor–induced vascular alteration in mouse healthy tissues Yunlong Yanga,b,1, Yin Zhanga,1,